Magnus Göran Gram

Title: Innovations by Magnus Göran Gram in Kidney Protection

Introduction

Magnus Göran Gram is a notable inventor based in Oxie, Sweden. He has made significant contributions to the field of medical technology, particularly in the area of kidney protection during radionuclide therapy. His innovative approach has the potential to enhance treatment outcomes for patients undergoing various malignancy therapies.

Latest Patents

Gram holds a patent for "Alpha-1-microglobulin for use in the protection of kidneys in radionuclide therapy." This invention relates to α-microglobulin (A1M) for use in the diagnosis or treatment of malignancies requiring radionuclide diagnostics (RD), radionuclide therapy (RNT), or radioimmunotherapy (RIT). A1M is utilized as a co-treatment to RD, RNT, or RIT, showcasing its importance in improving patient care.

Career Highlights

Magnus Göran Gram is associated with Guard Therapeutics International AB, where he continues to develop innovative solutions for medical challenges. His work focuses on enhancing the safety and efficacy of treatments involving radionuclides, which are critical in modern oncology.

Collaborations

Gram collaborates with esteemed colleagues such as Bo Åkerström and Sven-Erik Strand. Their combined expertise contributes to advancing research and development in the field of kidney protection and radionuclide therapy.

Conclusion

Magnus Göran Gram's contributions to medical technology, particularly through his patent on α-microglobulin, highlight his commitment to improving patient outcomes in cancer treatment. His work exemplifies the impact of innovation in healthcare.